Zoetis (ZTS) Shares Outstanding (2012 - 2026)
Zoetis' (ZTS) quarterly Shares Outstanding (Entity) came in at $414.2 million in Q2 2026, down 6.71% year-over-year from $443.9 million in Q2 2025, and down 1.47% quarter-over-quarter from $420.3 million in Q1 2026.
Analysis
Zoetis (ZTS) Shares Outstanding (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Shares Outstanding (Entity) for 15 consecutive years, with $414.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) fell 6.71% year-over-year to $414.2 million in Q2 2026; TTM through Jun 2026 was $414.2 million, a 6.71% decrease from a year earlier, with the FY2025 full-year figure at $424.9 million, down 5.31% from the prior year.
- Shares Outstanding (Entity) was $414.2 million for Q2 2026 at Zoetis, down from $420.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $471.2 million in Q1 2022 and troughed at $414.2 million in Q2 2026.
- A 5-year average of $450.7 million and a median of $455.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) retreated 0.79% in 2022 and slipped 6.71% in 2026, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $463.8 million in 2022, then slipped by 1.17% to $458.4 million in 2023, then fell by 2.1% to $448.7 million in 2024, then declined by 5.31% to $424.9 million in 2025, then fell by 2.54% to $414.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $414.2 million (Q2 2026), $420.3 million (Q1 2026), and $424.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.71 Bn | 40.52 Bn | 779.09 Mn | 78.95 Mn |
| 2 | Zoetis | 30.68 Bn | 29.01 Bn | 1.05 Bn | 417.60 Mn |
| 3 | Elanco Animal Health | 11.86 Bn | 11.33 Bn | 798.00 Mn | 499.50 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 40.55 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 9.06 Mn |
| 6 | Zhengye Biotechnology Holding | 75.76 Mn | 68.66 Mn | - | 47.35 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 48.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 417.60 Mn |
| Mar 31, 2026 | 422.10 Mn |
| Dec 31, 2025 | 443.44 Mn |
| Sep 30, 2025 | 442.90 Mn |
| Jun 30, 2025 | 445.10 Mn |
| Mar 31, 2025 | 447.60 Mn |
| Dec 31, 2024 | 454.20 Mn |
| Sep 30, 2024 | 452.90 Mn |
| Jun 30, 2024 | 455.50 Mn |
| Mar 31, 2024 | 458.00 Mn |
| Dec 31, 2023 | 461.17 Mn |
| Sep 30, 2023 | 460.30 Mn |
| Jun 30, 2023 | 461.90 Mn |
| Mar 31, 2023 | 463.50 Mn |
| Dec 31, 2022 | 468.89 Mn |
| Sep 30, 2022 | 467.80 Mn |
| Jun 30, 2022 | 470.00 Mn |
| Mar 31, 2022 | 472.20 Mn |
| Dec 31, 2021 | 474.35 Mn |
| Sep 30, 2021 | 474.00 Mn |